Request Demo

Last update 08 May 2025

Yunnan Shineway Spirin Pharmaceutical Co., Ltd.

Company|2014|Yunnan Sheng, China

Last update 08 May 2025

Overview

Pipeline

Deal

Translational Medicine

Overview

100 Clinical Results associated with Yunnan Shineway Spirin Pharmaceutical Co., Ltd.

0 Patents (Medical) associated with Yunnan Shineway Spirin Pharmaceutical Co., Ltd.

Literatures (Medical) associated with Yunnan Shineway Spirin Pharmaceutical Co., Ltd.

Fujian Fenxi Ceshi

Evaluation of uncertainty in determination of total aerobic bacteria in formula granules of Radix Polygoni Multiflori Preparata

Author: Li Jun-shan ; Zhou Chong-fu ; Tian Shu-xing ; Wu Yong-fang

Objective:Objective:Evaluating the uncertainty of the determination of aerobic bacteria in the formula granules of Radix Polygoni Multiflori Preparata.Methods:The total number of aerobic bacteria in Radix Polygoni Multiflori Preparata formula granules was determined by using the four non-sterile product microbial limit inspection method of the Chinese Pharmacopoeia 2020 edition.Through establishment of the math. model, identifying and analyzing the sources of uncertainty, quantifying each componens, and synthesizing the relative standard uncertainty and expanded uncertainty of measurement results.Results:The expanded uncertainty is U= 0.0826 log10(cfu/g), the interval of numerical value is(2.4426±0.0826)log10(cfu/g), and the interval of neg. number is(230, 340)cfu/g, k=2.Conclusion:The contribution of uncertainty introduced by electronic balance is small, The uncertainty caused by the preparation of test solution, diluent sample addition and repeatability experiment contributed a lot.

Shipin Anquan Zhiliang Jiance Xuebao

Uncertainty evaluation for the determination of nitrogen content in Spirulina tablets by constant method

Author: Zhou Chong-fu ; Zhou Xin ; Li Jin-long ; Tian Shu-xing ; Li Guo-ping

Objective To evaluate the uncertainty for the determination of nitrogen content in Spirulina tablets by constant method.Methods The first method(constant method) in the fourth nitrogen determination method of the Chinese pharmacopoeia 2015 edition was used to determine the nitrogen content in Spirulina tablets.The uncertainty of determination of nitrogen content in spirulina tablets was evaluated through the obtained test data.Results When the nitrogen content was 20.59 mg/tablet, the standard uncertainty for the determination of nitrogen content in Spirulina tablets by constant method was 0.197 mg/tablet, the extended uncertainty was 0.39 mg/tablet, and the determination result of nitrogen content in Spirulina tablets was(20.59±0.39) mg/tablet(k=2, P=95%).Conclusion The uncertainties of measurement mainly come from the repeatability experiment of sample determination, sulfuric acid standard solution, titration process, digestion and distillation of sample, and the uncertainty contribution of sample weighing is small.

100 Deals associated with Yunnan Shineway Spirin Pharmaceutical Co., Ltd.

100 Translational Medicine associated with Yunnan Shineway Spirin Pharmaceutical Co., Ltd.

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 18 Jan 2026

No data posted

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

Yunnan Shineway Spirin Pharmaceutical Co., Ltd.

Overview

Related

Corporation Tree

Pipeline

Pipeline Snapshot as of 18 Jan 2026

Deal

Translational Medicine

Profit

Grant & Funding(NIH)

Investment

Financing